Submissions

Author Guidelines

Author Guidelines

All CORRESPONDENCE for the journal should be sent to the following physical or electronic address. Please include the manuscript ID with all correspondence (example: mgpam-2017-0059):

The MGPAM Editorial Office
Phone: (994) 50 349-29-48; E-mail: editor@mgpam.az  and uptodate.az@gmail.com

Uptodate In Medicine LLC Health Sciences Publishing

Uptodate In Medicine LLC Health Sciences Publishing is the nationwide health organization dedicated to eliminating human disease as a major health problem by preventing disease, saving lives and diminishing suffering through research, education, training and advocacy.

SUBMISSION GUIDELINES

Manuscripts must be submitted to mgpam via www.mgpam.az portal. Please contact the mgpam Editorial Office at (994) 50 349 29 48 or editor@mgpam.az if you have any questions about submitting your manuscript online. 

• In some exceptional cases manuscripts may be submitted by e-mail.
• Submit text files only as .DOC, .DOCX, or .RTF file formats. Other file formats are not permitted and should be converted to .DOC or .DOCX.
• Authors are required to email or upload any permissions that may have been obtained for figures or tables or any permissions required for patient consent.
• Please include the permanent manuscript ID on all correspondence (example mgpam-2017-0059).

Author Withdrawal Policy
From time to time, an author may wish to withdraw a manuscript after submitting it. It is an author’s prerogative and we respect that decision. And an author is free to withdraw an article at no charge – as long as it is withdrawn within 15 days of its initial submission. If you have concerns or questions about it, please contact us for details.

Presubmission Inquiries
Due to the high volume of submissions we receive, mgpam considers presubmission inquiries on case-by-case basis. Instead, please submit full manuscripts online at www.mgpam.az and we will assist you in every way we can.

Tobacco Policy
The mgpam will not consider any work that is funded directly or indirectly by tobacco companies or their affiliates. Any such work will be editorially rejected. 

Copyright

Upon receipt of accepted manuscripts at mgpam, authors will be required to complete an copyright licence to publish form. Authors are hereby informed that by submitting an article for publication they confirm being the corresponding/submitting author and that Eurasian Journal of Clinical Sciences (mgpam) may retain their email address and other contact details for the purpose of communicating with them about the article. Authors shall agree to notify mgpam immediately about changes in their contact details. If article is accepted for publication, mgpam will contact corresponding authors initially using the email address that was used in the registration process. 

Manuscript Types
Papers that exceed the length limitations as described in this guide will not be considered for review.

• Original (Clinical Research) Articles: Scientific reports of the results of original clinical research. The text is limited to 5000 words including the title page, abstract, text, references, and tables. Abstracts are limited to 250 words.
• Original (Public Health Research) Articles: original research, including evaluations of public health interventions or programmes, and public health practice original work on audit, workforce or resource development. The text is limited to 5000 words including the title page, abstract, text, references, and tables. Abstracts are limited to 250 words.
• Systematic reviews and Meta-Analyses: The review should be less than 5000 words (not including abstract, references, and tables). There should be a structured abstract of up to 300 words (using the headings: Background, Methods, Results, and Conclusions). There should be upto 5 keywords and up to 40 references. 
• Review Articles: A timely, in-depth and detailed review and discussion of a particular health issue, medical problem or disease. Review articles are generally solicited by the editors. mgpam would on case-by-case basis but unsolicited materials will be considered. Review articles must be no longer than 5000 words including title page, abstract (no more than 250 words), text, tables, and references.
• Clinical case/Short reports: Short reports follow the same format as original articles. However, the short reports should contain less than 1200 words, and also maximum one table or figure. Abstracts are required with short reports, but should not be structured, and be no longer than 100 words. Maximum number of allowed references is 10 per each short report.
• Editorials: Opinions of recognized leaders in various fields of medical and public health specialties. Editorials are usually solicited by the Editor-in-Chief and in some circumstances by section editors and are related to a manuscript in the same issue. Length should not exceed 1500 words with no more than 15 references.
• Commentaries: Presents a point of view of general interest not related to an article in the same issue of mgpam issue.
• Letter to editor. Letters to the Editor discuss a specific publication by the Eurasian Journal of Clinical Sciences and have a word limit of 800.

Permissions

Use of previously published or copyrighted material

Information obtained and used from another source must be properly cited. The submitting author is responsible for obtaining written permission from the appropriate authors and/or copyright holders to use previously published or copyrighted material. Signed permission statements from the authors or copyright holders of original text or information shall be sent to the mgpam's Editorial Office along with manuscript submission.

Authorship by Residents and Fellows

Medical students, residents, and fellows may submit articles and may be listed as first author. However, UIMJ policy requires that a senior physician has provided mentoring support to the student, resident or fellow. This senior physician(s) shall be listed as a coauthor.

REVIEW PROCESS

Editorial and Peer Review
All submitted manuscripts are reviewed initially by the Editor-in-Chief for quality, novelty, scientific importance, and relevance to the journal's general audience. Manuscripts with insufficient priority for publication or those that are outside the scope of the journal are rejected promptly.

Manuscripts considered relevant are sent to Section Editors. Only these manuscripts will be reviewed by experts in the field. The Section Editors select the external peer reviewers and make the final decisions on manuscripts. mgpam employs a double-blind review process in which peer reviewer and author identities are kept confidential. The existence of a manuscript under review is not revealed to anyone other than the peer reviewers and editorial staff. Peer reviewers are required to maintain confidentiality about the manuscripts they review and must not divulge any information about a specific manuscript or its content to any third party without prior permission from the journal editors. All authors are sent notification of the receipt of manuscripts and editorial decisions made, by e-mail. 

Fast-Track Review

In some case mgpam's Editor can expedite a review of a paper. The need for expedited or fast-track review shall be indicated in the cover letter with reason explained. Only manuscripts that deserve rapid review and publication will be fast-tracked by Editor-in-Chief. 

Appeal Requests
Authors who wish to request reconsideration of a rejected manuscript should contact the Editorial Office at uptodate.az@gmail.com. Requests must include the manuscript ID (mgpam-2017-0059) and a detailed description of why the authors believe the paper should be reconsidered. If the appeal is allowed, instructions will be provided on how to resubmit your paper. 

Submissions from Editors
MGPAM works hard to ensure that any submission from the Editor-in-Chief or a member of the journal’s Editorial Board receives an objective evaluation. This is achieved by assigning any submitted manuscript from the Editor-in-Chief or an Editorial Board member to an impartial Section Editor who can maintain the integrity of the review process. In most cases, mgpam invites the External Guest Editors. 

Embargo Policy

Once your manuscript is submitted to mgpam, it is immediately embargoed from being presented or discussed elsewhere until one week before the publication date. Authors who discuss their work with the media in violation of above requirements must ensure that the media representatives know the embargo policy and the embargo date.

Authors can participate in scientific conferences prior to publication of their article in mgpam if their paper is in press (accepted and sent to production).

Author guidelines for discussing articles at scientific conferences:

• No article title and details shall be given out. However, it is allowed to discuss the findings and results of the work in general terms. A figure or table from submitted manuscript may be shown during the presentation.
• The copies of the manuscript, tables, or figures can not distributed.

If an embargo break is the result of any action by an author, the author risks withdrawal of publication of the manuscript.

Copyright Notice by publisher

©2021 Uptodate In Medicine LLC Health Sciences Publishing. All rights reserved. Unauthorized use prohibited. 

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

CME Articles of the Month

The mgpam CME Program is a comprehensive home study program based on the most clinically relevant mgpam articles.